Table 1 Ocular follow-up
Patient no. | Sex | Age at DOP (years) | f/u time (weeks) | V/A DOP logMar (R/L) | V/A last visit logMar (R/L) | V/A improv. | Near V/A at f/u logMar (R/L) | Autofluo at f/u | Amsler test | mfERG at f/u | 30° perimetry MD in db (R/L), group |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 24 | 1 | 0/0 | 0/0 | No | nd | No f/u | nd | No f/u | nd |
2 | F | 24 | 4 | 0/1.54 | 0/0.3 | Yes | nd | No f/u | nd | No f/u | 1.9/4.1 1 |
3 | F | 35 | 42.57 | 0/0.1 | 0/0 | Yes | 0/0.1 | Scars | R > L metas | nd | 1.0/0.4 2 |
4 | F | 21 | 105 | 0/0 | 0/0 | No | nd | Scars | nd | nd | 1.0/1.3 2 |
5 | M | 31 | 55.14 | 0.1/0 | 0.1/0.1 | No | nd | Scars | nd | Pathol | −1.6/–1.3 2 |
6 | F | 28 | 149.14 | 0/0.1 | 0/0 | Yes | nd | Scars | nd | Pathol | 7.5/10.8 → 3.0/3.4 3 |
7 | F | 17 | 82.57 | 0/0 | 0/0 | No | nd | Scars | nd | Pathol | 0.7/0.8 2 |
8 | M | 58 | 85.71 | 1.3/0.9 | 0.2/0.4 | Yes | 0.15/0.52 | Scars | R/L metas | Pathol | 5.7/6.9 → 7.0/7.6 3 |
9 | F | 38 | 1.57 | 0.2/0 | 0.2/0 | No | nd | No f/u | nd | No f/u | nd |
10 | M | 32 | 263.29 | 0/0 | 0/0 | No | 0.1/0.1 | Scars | R/L metas | Pathol | 2.5/1.9 → 0.1/0.5 3 |
11 | F | 18 | 250 | 0.1/0 | 0/0 | Yes | 0/0 | Scars | R/L metas | Pathol | −0.7/–0.8 2 |
12 | M | 34 | 1.57 | 0.3/0.6 | 0.2/0.3 | Yes | nd | No f/u | nd | No f/u | nd |
13 | F | 16 | 114.57 | 0/0.9 | 0/0.1 | Yes | 0/0.1 | Scars | L > R scotoma | R norm, L pathol | 0.1/–0.2 2 |
14 | M | 17 | 27.43 | 0/0.7 | 0/0.3 | Yes | nd | No f/u | nd | No f/u | −0.4/1.4 1 |
15 | M | 28 | 59 | 0/0 | 0/0 | No | 0/0 | Scars | R metas | Pathol | 0.7/–0.7 → 0.7/–0.4 3 |
16 | M | 23 | 47.29 | 0/0 | 0/0 | No | 0/0 | Scars | R > L metas | R pathol; L norm | 0.2/–1.2 → −1.6/–1.8 3 |
17 | F | 50 | 30.86 | 0.4/0.1 | 0/0 | Yes | 0.2/0.2 | Scars | R/L metas | Pathola | 6.7/8.7 → 1.3/1.4 3 |
18 | M | 21 | 0 | 0/0 | 0/0 | No | 0/0 | Scars | L > R metas | L > R pathol | 0.2/–0.6 1 |